Inozyme Pharma Inc (NASDAQ: INZY) Received An 32.12% Gain In 6 Months – Here’s What To Expect
During the last session, Inozyme Pharma Inc (NASDAQ:INZY)’s traded shares were 0.77 million, with the beta value of the company hitting 2.29. At the end
During the last session, Inozyme Pharma Inc (NASDAQ:INZY)’s traded shares were 0.77 million, with the beta value of the company hitting 2.29. At the end
In last trading session, Inozyme Pharma Inc (NASDAQ:INZY) saw 0.45 million shares changing hands with its beta currently measuring 2.29. Company’s recent per share price
Inozyme Pharma Inc (NASDAQ:INZY) has a beta value of 2.29 and has seen 1.02 million shares traded in the last trading session. The company, currently
During the last session, Inozyme Pharma Inc (NASDAQ:INZY)’s traded shares were 3.82 million, with the beta value of the company hitting 2.22. The 52-week high
In the last trading session, 1.14 million shares of the Inozyme Pharma Inc (NASDAQ:INZY) were traded, and its beta was 2.07. Most recently the company’s
Inozyme Pharma Inc (NASDAQ:INZY)’s traded shares stood at 2.56 million during the last session, with the company’s beta value hitting 2.37.The INZY share’s 52-week high
In last trading session, Inozyme Pharma Inc (NASDAQ:INZY) saw 0.33 million shares changing hands with its beta currently measuring 1.53. Company’s recent per share price
© 2024, Powered by Smart TechOne